224 Direct-to-Consumer Advertising in Oncology T he O ncologist ® Finally, while studies specific to oncology are rare, Viale and Sanchez Yamamoto  surveyed 221 American oncology nurse practitioners (ONPs). Ninety-four percent reported having had a request for medication by a patient who had seen an advertisement, with 40% experiencing one to five requests per week. Fifty-two percent of the ONPs “never” felt pressured to prescribe, but 43% “sometimes” felt pressured to prescribe. Alarmingly, 74% said patients asked for inappropriate medications. Interestingly, 63% felt that direct-to-consumer advertising fostered patient–ONP dialogue. The authors concluded that direct-to-consumer advertising was prevalent in ONP–patient encounters and had the potential to influence prescribing behavior. Patient Outcomes How do patients’ attitudes about direct-to-consumer adver-tising affect their behavior? In a survey of 329 respondents from Sacramento, CA, Bell and associates showed that awareness of advertisements and respondents’ subsequent medication requests were both associated with prescrip-tion drug use in general, media exposure, positive attitudes toward direct-to-consumer advertising, poorer health, and better insurance coverage . Respondents were more likely to be aware of ads for treatments for the diseases they had; for example, asthmatics were twice as likely to be aware of advertisements for an asthma drug than those
This is the end of the preview.
access the rest of the document.